Immunogenicity and pharmacokinetics of guselkumab among patients with moderate‐to‐severe psoriasis in VOYAGE‐1 and VOYAGE‐2

Authors:

Abstract
No abstract available
Funding Information
  • Janssen Research and Development

This publication has 8 references indexed in Scilit: